Wells Fargo has improved efficiency and profitability but lacks significant revenue growth. Check out WFC stock's valuation ...
Wells Fargo executives welcomed Heather Blair to the bank’s technology team Monday. Blair was tapped for the role of CIO in ...
Wells Fargo upgraded Check Point (CHKP) to Overweight from Equal Weight with a price target of $280, up from $200. New CEO Nadav Zafrir is a ...
Bank of America Securities analyst Ebrahim Poonawala maintained a Buy rating on Wells Fargo (WFC – Research Report) today. The company’s shares ...
1d
Stocktwits on MSNWells Fargo Stock Upgraded By RBC Capital, Analyst Expects Bank To See Regulatory Benefit — Retail Sentiment ImprovesWells Fargo & Co (WFC) shares traded in the green on Thursday after RBC Capital analyst Gerard Cassidy upgraded the stock to ...
Business Insider's personal finance team compared Wells Fargo savings accounts to the best high-yield savings accounts and found them to be a standard offering. One of its accounts can offer good ...
NetApp intends to use a portion of the net proceeds of this offering to repay its $750 million outstanding principal amount of 1.875% Senior Notes due 2025 at maturity and the remainder of the net ...
2d
Zacks Investment Research on MSNInvestors Heavily Search Wells Fargo & Company (WFC): Here is What You Need to KnowWells Fargo (WFC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
See reviews below to learn more or submit your own review. Wells Fargo (NMLS #399801), one of the biggest financial services companies in the country, provides home purchase and refinance loans in ...
Cardholders can rack up triple points across a wide swath of common spending categories like dining, travel, gas stations and streaming — all while paying no annual fee. This card offers ...
Northern Trust (NASDAQ:NTRS – Free Report) had its price objective lowered by Morgan Stanley from $138.00 to $136.00 in a ...
Wells Fargo & Company started coverage on shares of BioNTech in a research report on Wednesday, December 11th. They issued an “overweight” rating and a $170.00 target price on the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results